Korean J Anat.
2003 Aug;36(4):257-264.
Quantitative Analysis of Agmatine by HPLC in Ischemic Brain
- Affiliations
-
- 1Department of Anatomy, Yonsei University College of Medicine, Seoul 120-752, Korea.
- 2BK21 Project for Medical Sciences, Department of Anatomy, Yonsei University College of Medicine, Seoul 120-752, Korea. jelee@yumc.yonsei.ac.kr
Abstract
- Agmatine, a widely distributed molecule in mammalian tissues, shows neuroprotective effects in brain ischemia. We describe the neuroprotective effects of agmatine in the mouse MCAO model and the quantitative change of agmatine in ischemic injury. Brain ischemic injured mice were injected with agmatine (100 mg/kg of mouse, IP). Agmatine significantly reduced the infarct area after MCAO. Despite the similar patterns of agmatine change observed in control or agmatine injected animals, the agmatine levels of the penumbra were significantly higher than those of the striatum and the cerebral cortex during the early period (<1 hour after 2 hours of MCA occlusion). This suggests that the early period, during which agmatine levels increase in the brain, is the crucial period in terms of neuroprotective effect during ischemia.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Endogenous Agmatine Induced by Ischemic Preconditioning Regulates Ischemic Tolerance Following Cerebral Ischemia
- Role of agmatine in the application of neural progenitor cell in central nervous system diseases: therapeutic potentials and effects
- Regulation of endothelial nitric oxide synthase by agmatine after transient global cerebral ischemia in rat brain
- The Effect of Agmatine on Expression of MMP2 and MMP9 in Cerebral Ischemia
- Agmatine Attenuates Nitric Oxide Synthesis and Protects ER-structure from Global Cerebral Ischemia in Rats
